Sunshine Biopharma Inc. -27SBFMWPreferred / convertible
13F holders, Q2 2026 (June 30)3holders +2
2new positions
0sold out
$0.04avg. 13F price*
At the end of Q2 2026, 3 institutions reported holding Sunshine Biopharma Inc. -27 (SBFMW) in their 13F filings, up 2 from Q1 2026. 2 opened new positions and 0 sold out. The largest holders were HRT Financial LP ($2K), UBS Group AG ($546) and Clear Street Group Inc. ($27).
- Company
- Sunshine Biopharma Inc. -27
- CUSIP
- 867781502
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 53,065 shares bought and 12,000 shares sold, net +41,065 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| HRT Financial LP | — | New | 52,616 | $2K |
| UBS Group AG | — | Reduce -50.3% | 11,879 | $546 |
| Clear Street Group Inc. | — | New | 449 | $27 |
"% of holder's portfolio" is SBFMW's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. -27 the manager owns.